HER2 mutations and overexpression, while predominantly linked to breast cancer, are also present in other solid tumors, including lung and stomach cancers, where they exacerbate tumor aggressiveness and lead to inferior outcomes [13,36,37,38]. The gene discussed is ERBB2; the disease is breast cancer.